Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Baselga

Showing results (1-10 of 168) with videos related to

Pageof 17
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2001
Phase I and II clinical trials of trastuzumabJ Baselga
Oncology|November 6, 2001
Herceptin alone or in combination with chemotherapy in the treatment of HER2-positive metastatic breast cancer: pivotal trialsJ Baselga
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 20, 2008
Novel agents in the era of targeted therapy: what have we learned and how has our practice changed?J Baselga
European Journal of Cancer (Oxford, England : 1990)|February 13, 2001
Clinical trials of Herceptin(trastuzumab)J Baselga
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2010
Treatment of HER2-overexpressing breast cancerJ Baselga
Seminars in Oncology|October 26, 2000
Clinical trials of single-agent trastuzumab (Herceptin)J Baselga
Seminars in Oncology|October 26, 2000
Current and planned clinical trials with trastuzumab (Herceptin)J Baselga
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2001
Is circulating HER-2 more than just a tumor marker?J Baselga
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 2000
Monoclonal antibodies directed at growth factor receptorsJ Baselga
European Journal of Cancer (Oxford, England : 1990)|May 9, 2001
Clinical trials of Herceptin(R) (trastuzumab)J Baselga
Pageof 17

Showing results (1-10 of 168) with videos related to

Sort By:
Pageof 17
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2001
Phase I and II clinical trials of trastuzumabJ Baselga
Oncology|November 6, 2001
Herceptin alone or in combination with chemotherapy in the treatment of HER2-positive metastatic breast cancer: pivotal trialsJ Baselga
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 20, 2008
Novel agents in the era of targeted therapy: what have we learned and how has our practice changed?J Baselga
European Journal of Cancer (Oxford, England : 1990)|February 13, 2001
Clinical trials of Herceptin(trastuzumab)J Baselga
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2010
Treatment of HER2-overexpressing breast cancerJ Baselga
Seminars in Oncology|October 26, 2000
Clinical trials of single-agent trastuzumab (Herceptin)J Baselga
Seminars in Oncology|October 26, 2000
Current and planned clinical trials with trastuzumab (Herceptin)J Baselga
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2001
Is circulating HER-2 more than just a tumor marker?J Baselga
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 2000
Monoclonal antibodies directed at growth factor receptorsJ Baselga
European Journal of Cancer (Oxford, England : 1990)|May 9, 2001
Clinical trials of Herceptin(R) (trastuzumab)J Baselga
Pageof 17